US Patent 7265138 Vanilloid receptor ligands and their use in treatments
Patent 7265138 was granted and assigned to Amgen on September, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 7 Aug, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
0
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+53 characters)
Article
Patent abstract
Compounds having the general structure
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07265138 Vanilloid receptor ligands and their use in treatments US Patent 7265138 Vanilloid receptor ligands and their use in treatments
Infobox
Patent Number
0726513800
Patent Number
726513800
Edits on 7 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
072651380
Date of Patent
September 4, 2007
0Patent Application Number
107759800
Date Filed
February 9, 2004
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
072651380
Date of Patent
September 4, 2007
0Patent Application Number
107759800
Date Filed
February 9, 2004
0Official Website
Patent Primary Examiner
Edits on 16 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 22 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07265138 Vanilloid receptor ligands and their use in treatments
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07265138
Date of patent
September 4, 2007
Patent application number
10775980
Date Filed
February 9, 2004
Patent primary examiner
Find more entities like US Patent 7265138 Vanilloid receptor ligands and their use in treatments
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
